Repositorio
Cómo publicar
Recursos
FAQs

Mostrar el registro sencillo del ítem

Inhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy

dc.contributor.authorSica, Valentina
dc.contributor.authorPedro, J. M. B. S.
dc.contributor.authorChen, G.
dc.contributor.authorMariño García, Guillermo 
dc.contributor.authorLachkar, Sylvie
dc.contributor.authorIzzo, V.
dc.contributor.authorMaiuri, Maria Chiara
dc.contributor.authorNiso-Santano, Mireia
dc.contributor.authorKroemer, Guido
dc.date.accessioned2018-02-28T10:41:20Z
dc.date.available2018-02-28T10:41:20Z
dc.date.issued2017
dc.identifier.citationOncotarget, 8(52), p. 89527-89538 (2017); doi:10.18632/oncotarget.19033
dc.identifier.issn1949-2553
dc.identifier.urihttp://hdl.handle.net/10651/46248
dc.description.sponsorshipWe are grateful to Jean-Christophe Rain, Drs O Geneste and JA Hickman (Institut de Recherche Servier, Croissy sur Seine, France) for sharing data on the Beclin 1 interactome and the Hybrigenics team for excellent technical assistance. We are indebted to Prof. Berth Vogelstein for TP53 and EP300 knockout cells. G.M. is funded by the Ramon y Cajal Program (RYC-2013-12751) and supported by Spain's Ministerio de Economia y Competitividad, BFU2015-68539 and the BBVA foundation, SV-15-FBBVA-2. M. N-S was supported by "Contrato Juan de la Cierva" (JCI-2012-14383) from Ministerio de Economia y Competitividad, Spain. GK is supported by the Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR) - Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canceropole Ilede-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumiere, the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI).
dc.format.extentp. 89527-89538
dc.language.isoeng
dc.relation.ispartofOncotarget, 8
dc.rights© 2017 Valentina Sica et al.
dc.rightsCC Reconocimiento 3.0 Unported
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85032296780&doi=10.18632%2foncotarget.19033&partnerID=40&md5=8e748eb7eb1b4442aa3f04d5c5f14b06
dc.titleInhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy
dc.typejournal article
dc.identifier.doi10.18632/oncotarget.19033
dc.relation.projectIDRamon y Cajal Program /RYC-2013-12751
dc.relation.projectIDMINECO/BFU2015-68539
dc.relation.projectIDJCI-2012-14383
dc.relation.publisherversionhttp://dx.doi.org/10.18632/oncotarget.19033
dc.rights.accessRightsopen access


Ficheros en el ítem

untranslated
Nombre:
Inhibitor of growth.pdf
Tamaño:
8.124Mb
Formato:
PDF

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2017 Valentina Sica et al.
Este ítem está sujeto a una licencia Creative Commons